The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALPHABET INC | CAP STK CL C | 02079K107 | 21,258,618 | 15,900 | SH | SOLE | 15,900 | 0 | 0 | |||
| DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 6,589,162 | 105,867 | SH | SOLE | 105,867 | 0 | 0 | |||
| FREEPORT-MCMORAN INC | CL B | 35671D857 | 16,400,000 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | |||
| GLU MOBILE INC | COM | 379890106 | 15,336,750 | 2,535,000 | SH | SOLE | 2,535,000 | 0 | 0 | |||
| PAYPAL HLDGS INC | COM | 70450Y103 | 12,115,040 | 112,000 | SH | SOLE | 112,000 | 0 | 0 | |||
| SAGE THERAPEUTICS INC | COM | 78667J108 | 13,716,100 | 190,000 | SH | SOLE | 190,000 | 0 | 0 | |||
| SYNNEX CORP | COM | 87162W100 | 15,710,251 | 121,974 | SH | SOLE | 121,974 | 0 | 0 | |||
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 13,465,425 | 61,500 | SH | SOLE | 61,500 | 0 | 0 | |||